Spiro Medical
- Business Model
- B2B
- Website
- spiro-medical.com
- Total Funding
- $67.0M
- Last Round
- $67.0M Series AJan 2026
- Rounds
- 1
About
Spiro Medical develops the Spiro Neuromodulation System, a device-based therapy targeting severe chronic airway diseases such as asthma and COPD. The company is focused on transforming the treatment paradigm for patients who have exhausted conventional options.
Summary
Spiro Medical is a Healthcare company. It has raised $67.0M in total across 1 round, most recently a $67.0M Series A round in Jan 2026. Investors include Andera Partners, Sherpa Healthcare Partners and Omega Funds.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2026
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe